Abdominal aortic aneurysm (AAA) is a degenerative vascular pathology resulting in
significant morbidity and mortality in older adults due to rupture and sudden death. Despite …

Objective Most abdominal aortic aneurysms (AAAs) contain intraluminal thrombus (ILT),
which has been demonstrated to contain proteolytic enzymes and proinflammatory cytokines …

Background: Abdominal aortic aneurysm (AAA), a common disease involving the segmental
expansion and rupture of the aorta, has a high mortality rate. Therapeutic options for AAA …

Abdominal aortic aneurysm (AAA) rupture has been recognized as a significant cause of
mortality for adults aged 60 years in the developed world for some time. 1 AAAs are usually …

The cardiovascular field is still searching for a treatment for abdominal aortic aneurysms
(AAA). This inflammatory disease often goes undiagnosed until a late stage and associated …

Abdominal aortic aneurysm (AAA) is a severe vascular disease and a major public health
issue with an unmet medical need for therapy. This disease is featured by a progressive …

Objective This review describes ongoing efforts to develop a medical therapy to limit
abdominal aortic aneurysm (AAA) growth. Methods Data from animal model studies, human …

Aneurysm-induced disseminated intravascular coagulopathy (DIC) constitutes a rare
presentation form of aortic aneurysms. The majority of DIC cases are asymptomatic and this …

Abdominal aortic aneurysm (AAA) causes∼ 170 000 deaths annually worldwide. Most
guidelines recommend asymptomatic small AAAs (30 to< 50 mm in women; 30 to< 55 mm in …

Abstract Background Abdominal aortic aneurysms (AAAs) represent a complex multifactorial
hemodynamic, thrombotic, and inflammatory process that can ultimately result in aortic …